reglab/housing_qa huggingface dataset:
22 ME Rev Stat § 6203 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6203. Rules; agreements

 §6203. Rules; agreements 1.  Rules.  The department shall promulgate such rules as may be necessary for the effective administration of adult day care pursuant to this chapter, in accordance with the Maine Administrative Procedure Act, Title 5, chapter 375. In the development of these rules, the department shall consult with the Maine Committee on Aging, the associations representing care facilities and area agencies on aging.   [PL 1989, c. 347, §9 (AMD).] 2.  Agreements.  In order to provide adult day care and other services, the department may enter into agreements with long-term health care facilities and community-based programs, separate and distinct from any other agreements between the department and the same facility or programs.   Any facility or program providing adult day care pursuant to this chapter shall enter into an agreement with the department. Each agreement shall specify, among other things, the services to be provided, the fees for services, the method of payment, records to be maintained and the provisions for evaluating the services provided.   [PL 1989, c. 329, §22 (AMD); PL 1989, c. 347, §9 (AMD); PL 1989, c. 878, Pt. A, §64 (RPR).] SECTION HISTORY PL 1983, c. 545, §1 (NEW). PL 1989, c. 329, §22 (AMD). PL 1989, c. 347, §9 (AMD). PL 1989, c. 878, §A64 (AMD).
22 ME Rev Stat § 6204 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6204. Sites; other services (REPEALED)

 §6204. Sites; other services (REPEALED)SECTION HISTORY PL 1983, c. 545, §1 (NEW). PL 1989, c. 329, §23 (AMD). PL 1989, c. 347, §10 (RP). PL 1989, c. 878, §B20 (RP).
22 ME Rev Stat § 6205 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6205. Fees (REPEALED)

 §6205. Fees (REPEALED)SECTION HISTORY PL 1983, c. 545, §1 (NEW). PL 1989, c. 347, §10 (RP).
22 ME Rev Stat § 6206 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6206. Eligibility (REPEALED)

 §6206. Eligibility (REPEALED)SECTION HISTORY PL 1983, c. 545, §1 (NEW). PL 1989, c. 347, §10 (RP).
22 ME Rev Stat § 6207 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6207. Payment (REPEALED)

 §6207. Payment (REPEALED)SECTION HISTORY PL 1983, c. 545, §1 (NEW). PL 1989, c. 347, §10 (RP).
22 ME Rev Stat § 6208 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6208. Report

 §6208. Report A report of services provided pursuant to this chapter shall be included in the annual Maine Social Services Report.   [PL 1989, c. 347, §11 (RPR).]SECTION HISTORY PL 1983, c. 545, §1 (NEW). PL 1989, c. 347, §11 (RPR).
22 ME Rev Stat § 6209 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 2: PRIORITY SOCIAL SERVICES PROGRAM|Chapter 1505: ADULT DAY CARE|22 §6209. Funds

 §6209. Funds 1.  Distribution.  The department shall disburse funds, pursuant to this Subtitle, in a manner that ensures, to the extent practicable, equitable distribution of services among adults with long-term care needs and the various regions of the State.   [PL 1989, c. 347, §12 (NEW).] 2.  Fee scale.  The department shall develop, wherever practicable, sliding fee scales for adult day care services provided pursuant to this Subtitle.   [PL 1989, c. 347, §12 (NEW).] SECTION HISTORY PL 1989, c. 347, §12 (NEW).
22 ME Rev Stat § 7245 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7245. Legislative intent

 §7245. Legislative intent It is the intent of the Legislature that the prescription monitoring program established pursuant to this chapter serve as a means to promote the public health and welfare and to detect and prevent substance use disorder. This chapter is not intended to interfere with the legitimate medical use of controlled substances.   [PL 2017, c. 407, Pt. A, §87 (AMD).]SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2017, c. 407, Pt. A, §87 (AMD).
22 ME Rev Stat § 7246 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7246. Definitions

 §7246. Definitions As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings.   [PL 2003, c. 483, §1 (NEW).]1.  Controlled substance.  "Controlled substance" means a controlled substance included in schedules II, III or IV of 21 United States Code, Section 812 or 21 Code of Federal Regulations, Section 1308.   [PL 2003, c. 483, §1 (NEW).] 1-A.  Acute pain.  "Acute pain" means pain that is the normal, predicted physiological response to a noxious chemical or thermal or mechanical stimulus. "Acute pain" typically is associated with invasive procedures, trauma and disease and is usually time-limited.   [PL 2015, c. 488, §1 (NEW).] 1-B.  Administer.  "Administer" means an action to apply a prescription drug directly to a person by any means by a licensed or certified health care professional acting within that professional's scope of practice. "Administer" does not include the delivery, dispensing or distribution of a prescription drug for later use.   [PL 2015, c. 488, §1 (NEW).] 1-C.  Chronic pain.  "Chronic pain" means pain that persists beyond the usual course of an acute disease or healing of an injury. "Chronic pain" may or may not be associated with an acute or chronic pathologic process that causes continuous or intermittent pain over months or years.   [PL 2015, c. 488, §1 (NEW).] 2.  Dispenser.  "Dispenser" means:   A. A pharmacist who is licensed or registered under Title 32; or   [PL 2017, c. 360, §1 (NEW).]B. A veterinarian licensed under Title 32, chapter 71-A with authority to dispense a benzodiazepine or an opioid medication.   [PL 2017, c. 360, §1 (NEW).][PL 2017, c. 360, §1 (RPR).] 3.  Fund.  "Fund" means the Controlled Substances Prescription Monitoring Program Fund established in section 7247.   [PL 2003, c. 483, §1 (NEW).] 4.  Office.   [PL 2011, c. 657, Pt. AA, §65 (RP).] 5.  Prescriber.  "Prescriber" means a licensed health care professional with authority to prescribe controlled substances.   [PL 2017, c. 360, §2 (AMD).] 6.  Prescription monitoring information.  "Prescription monitoring information" means information submitted to and maintained by the program.   [PL 2003, c. 483, §1 (NEW).] 7.  Program.  "Program" means the Controlled Substances Prescription Monitoring Program established under section 7248.   [PL 2003, c. 483, §1 (NEW).] SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2003, c. 689, §B6 (REV). PL 2011, c. 657, Pt. AA, §65 (AMD). PL 2015, c. 488, §§1, 2 (AMD). PL 2017, c. 213, §2 (AMD). PL 2017, c. 360, §§1, 2 (AMD).
22 ME Rev Stat § 7247 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7247. Controlled Substances Prescription Monitoring Program Fund

 §7247. Controlled Substances Prescription Monitoring Program Fund The Controlled Substances Prescription Monitoring Program Fund is established within the department to be used by the commissioner to fund or assist in funding the program. Any balance in the fund does not lapse but is carried forward to be expended for the same purposes in succeeding fiscal years. The fund must be deposited with and maintained and administered by the department. The commissioner may accept funds into the fund from any source, public or private, including grants or contributions of money or other things of value, that the commissioner determines necessary to carry out the purposes of this chapter. Money received by the department to establish and maintain the program must be used for the expenses of administering this chapter.   [PL 2011, c. 657, Pt. AA, §66 (AMD).]SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2011, c. 380, Pt. WW, §1 (AMD). PL 2011, c. 657, Pt. AA, §66 (AMD).
22 ME Rev Stat § 7248 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7248. Controlled Substances Prescription Monitoring Program

 §7248. Controlled Substances Prescription Monitoring Program 1.  Establishment of monitoring program.  Contingent upon the receipt of funds pursuant to section 7247 sufficient to carry out the purposes of this chapter, the Controlled Substances Prescription Monitoring Program is established. No later than January 2, 2004, to implement the program, the department shall establish an electronic system for monitoring any controlled substance that is dispensed to a person in the State by a dispenser.   [PL 2011, c. 657, Pt. AA, §67 (AMD).] 2.  Contract for services.  The department may contract with a vendor to establish and maintain the program pursuant to rules adopted by the department.   [PL 2011, c. 657, Pt. AA, §67 (AMD).] 3.  Information available.  The program must rapidly provide information in an electronic format to prescribers and dispensers.   [PL 2003, c. 483, §1 (NEW).] SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2011, c. 657, Pt. AA, §67 (AMD).
22 ME Rev Stat § 7249-A (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7249-A. Reporting of methadone treatment with consent (WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2017, c. 243, §5)

 §7249-A. Reporting of methadone treatment with consent (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)(WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2017, c. 243, §5)1.  Consent form; methadone treatment.  The department shall develop a consent form to be presented to every patient receiving treatment at any facility that provides methadone for the treatment of opioid dependency. The form records the patient's identifying information along with consent to enter the name of the patient's methadone treatment facility and dosage information into the program. The form must be available to the facility for use in paper or electronic form. The contents of the form may be disclosed only in a medical emergency as described in section 7250, subsection 7. The patient may decline consent.   [PL 2017, c. 243, §2 (NEW); PL 2017, c. 243, §5 (AFF).] 2.  Treatment facility to enter information into the program.  For a patient who has provided consent pursuant to subsection 1, a prescriber or the prescriber's designee at a facility that provides methadone for the treatment of opioid dependency shall enter the patient's identifying information along with the name of the methadone treatment facility and the dosage information into the program. Dosage information must be entered at the beginning of treatment, after the first 90 days of treatment and every 180 days after that. If a patient ceases treatment or moves to a different facility, the patient's methadone treatment facility must notify the program within 30 days of that change in status.   [PL 2017, c. 243, §2 (NEW); PL 2017, c. 243, §5 (AFF).] 3.  Renewal of consent form.  A facility that provides methadone for the treatment of opioid dependency must provide a new consent form under subsection 1 to a patient annually and renew that patient's consent. The patient may choose to decline consent or void consent at any time.   [PL 2017, c. 243, §2 (NEW); PL 2017, c. 243, §5 (AFF).] SECTION HISTORY PL 2017, c. 243, §2 (NEW). PL 2017, c. 243, §5 (AFF).
22 ME Rev Stat § 7249-B (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7249-B. Opioid medication distribution monitoring information

 §7249-B. Opioid medication distribution monitoring information A manufacturer of an opioid medication that is available in this State and a wholesaler that sells or distributes an opioid medication in this State shall submit to the department, by electronic means or other format specified in a waiver granted by the department, information for this State submitted to the United States Drug Enforcement Administration's Automation of Reports and Consolidated Orders System pursuant to 21 United States Code, Subchapter I and 21 Code of Federal Regulations, Section 1304.33 at the time that information is submitted to the United States Drug Enforcement Administration. As used in this section, the terms "manufacturer" and "opioid medication" have the same meanings as in Title 32, section 13702‑A.   [PL 2019, c. 536, §2 (NEW).]SECTION HISTORY PL 2019, c. 536, §2 (NEW).
22 ME Rev Stat § 7251 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7251. Unlawful acts and penalties

 §7251. Unlawful acts and penalties 1.  Failure to submit information.  A dispenser who knowingly fails to submit prescription monitoring information to the department as required by this chapter commits a civil violation for which a fine of $250 per incident, not to exceed $5,000 per calendar year, may be adjudged and is subject to discipline by the Maine Board of Pharmacy pursuant to Title 32, chapter 117, subchapter 4, by the State Board of Veterinary Medicine pursuant to Title 32, chapter 71-A or by the applicable professional licensing entity.   [PL 2017, c. 360, §5 (AMD).] 2.  Unlawful disclosure or use of information.  A person who intentionally or knowingly uses or discloses prescription monitoring information in violation of this chapter, unless otherwise authorized by law, is guilty of a Class C crime.   [PL 2003, c. 483, §1 (NEW).] SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2011, c. 657, Pt. AA, §70 (AMD). PL 2015, c. 488, §8 (AMD). PL 2017, c. 360, §5 (AMD).
22 ME Rev Stat § 7252 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7252. Rulemaking

 §7252. Rulemaking The department may adopt rules necessary to implement the provisions of this chapter. Rules adopted pursuant to this section are major substantive rules as defined in Title 5, chapter 375, subchapter 2-A.   [PL 2011, c. 657, Pt. AA, §71 (AMD).]SECTION HISTORY PL 2003, c. 483, §1 (NEW). PL 2011, c. 657, Pt. AA, §71 (AMD).
22 ME Rev Stat § 7254 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1603: CONTROLLED SUBSTANCES PRESCRIPTION MONITORING|22 §7254. Exemption from opioid medication limits until January 2017; rulemaking

 §7254. Exemption from opioid medication limits until January 2017; rulemaking 1.  Exemption until January 2017.   [PL 2015, c. 488, §9 (NEW); MRSA T. 22 §7254, sub-§1 (RP).] 2.  Rulemaking.  Notwithstanding section 7252, no later than January 1, 2017, the department shall adopt routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A to establish reasonable exceptions to prescriber limits in Title 32, sections 2210, 2600‑C, 3300‑F, 3657 and 18308, including for chronic pain and acute pain. The rules must take into account clinically appropriate exceptions and include prescribers in the rule-making process including the drafting of draft rules and changes after the public hearing process to the extent permitted by Title 5, chapter 375. After July 1, 2017, any rules adopted by the department pursuant to this section are governed by section 7252.   [PL 2017, c. 213, §11 (AMD).] SECTION HISTORY PL 2015, c. 488, §9 (NEW). PL 2017, c. 213, §11 (AMD).
22 ME Rev Stat § 7261 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT|22 §7261. Purpose - Article 1

 §7261. Purpose - Article 1 The purpose of the interstate prescription monitoring program compact, referred to in this chapter as "the compact," is to provide a mechanism for state prescription monitoring programs to securely share prescription data to improve public health and safety. The compact is intended to:   [PL 2011, c. 217, §1 (NEW).]1.  Enhance state prescription monitoring programs.  Enhance the ability of state prescription monitoring programs, in accordance with state laws, to provide an efficient and comprehensive tool for:   A. Practitioners to monitor patients and support treatment decisions;   [PL 2011, c. 217, §1 (NEW).]B. Law enforcement officials to conduct diversion investigations when authorized by state law;   [PL 2011, c. 217, §1 (NEW).]C. Regulatory agencies to conduct investigations or other appropriate reviews when authorized by state law; and   [PL 2011, c. 217, §1 (NEW).]D. Other uses of prescription drug data authorized by state law for purposes of curtailing illegal substance use and diversion; and   [PL 2017, c. 407, Pt. A, §88 (AMD).][PL 2017, c. 407, Pt. A, §88 (AMD).] 2.  Provide technology infrastructure.  Provide a technology infrastructure to facilitate secure data transmission.   [PL 2011, c. 217, §1 (NEW).] SECTION HISTORY PL 2011, c. 217, §1 (NEW). PL 2017, c. 407, Pt. A, §88 (AMD).
22 ME Rev Stat § 7263 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT|22 §7263. Authorized uses and restrictions on prescription data - Article 3

 §7263. Authorized uses and restrictions on prescription data - Article 3 1.  Authority of member state.  Under the compact a member state:   A. Retains its authority and autonomy over its prescription monitoring program and prescription data in accordance with its laws, rules and policies;   [PL 2011, c. 217, §1 (NEW).]B. May provide, restrict or deny prescription data to a requestor of another state in accordance with the member state's laws, rules and policies;   [PL 2011, c. 217, §1 (NEW).]C. May provide, restrict or deny prescription data received from another state to a requestor within that state; and   [PL 2011, c. 217, §1 (NEW).]D. Has the authority to determine which requestors are authorized.   [PL 2011, c. 217, §1 (NEW).][PL 2011, c. 217, §1 (NEW).] 2.  Restrictions on prescription data.  Prescription data obtained by a member state pursuant to this compact has the following restrictions.   A. It must be used solely for purposes of providing the prescription data to a requestor.   [PL 2011, c. 217, §1 (NEW).]B. It may not be stored in the member state's prescription monitoring program database, except for stored images, nor in any other database.   [PL 2011, c. 217, §1 (NEW).][PL 2011, c. 217, §1 (NEW).] 3.  Limit on categories of requestors.  A member state may limit the categories of requestors of another member state that will receive prescription data.   [PL 2011, c. 217, §1 (NEW).] 4.  Requestor authentication.  The commission shall promulgate rules establishing standards for requestor authentication.   A. Every member state shall authenticate requestors according to the rules established by the commission.   [PL 2011, c. 217, §1 (NEW).]B. A member state may authorize its requestors to request prescription data from another member state only after such requestor has been authenticated.   [PL 2011, c. 217, §1 (NEW).]C. A member state that becomes aware of a requestor who violated the laws or rules governing the appropriate use of prescription data shall notify the state that transmitted the prescription data.   [PL 2011, c. 217, §1 (NEW).][PL 2011, c. 217, §1 (NEW).] SECTION HISTORY PL 2011, c. 217, §1 (NEW).
22 ME Rev Stat § 7264 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT|22 §7264. Technology and security - Article 4

 §7264. Technology and security - Article 4 1.  Security requirements.  The commission shall establish security requirements through rules for the transmission of prescription data.   [PL 2011, c. 217, §1 (NEW).] 2.  Open standards for technology infrastructure.  The commission shall foster the adoption of open standards for the technology infrastructure that are vendor-neutral and technology-neutral.   [PL 2011, c. 217, §1 (NEW).] 3.  Acquisition and operation of technology infrastructure.  The commission is responsible for acquisition and operation of the technology infrastructure.   [PL 2011, c. 217, §1 (NEW).] SECTION HISTORY PL 2011, c. 217, §1 (NEW).
22 ME Rev Stat § 7265 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT|22 §7265. Funding - Article 5

 §7265. Funding - Article 5 1.  Interstate commission responsible for funding compact.  The interstate commission, through its member states, is responsible for providing for the payment of the reasonable expenses for establishing, organizing and administering the operations and activities of the compact.   [PL 2011, c. 217, §1 (NEW).] 2.  Interstate commission may collect dues from member states.  The interstate commission may levy on and collect annual dues from each member state to cover the cost of operations and activities of the interstate commission and its staff, which must be in a total amount sufficient to cover the interstate commission's annual budget as approved each year. The aggregate annual dues amount must be allocated in an equitable manner and may consist of a fixed fee component as well as a variable fee component based upon a formula to be determined by the interstate commission, which shall promulgate a rule binding upon all member states. Such a formula must take into account factors including but not limited to the total number of practitioners or licensees within a member state. Fees established by the interstate commission may be recalculated and assessed on an annual basis.   [PL 2011, c. 217, §1 (NEW).] 3.  Interstate commission may accept nonstate funding.  Notwithstanding subsections 1 and 2 and any other provision of law, the interstate commission may accept nonstate funding, including grants, awards and contributions to offset, in whole or in part, the costs of the annual dues required under subsection 2.   [PL 2011, c. 217, §1 (NEW).] 4.  Interstate commission may not incur obligations prior to securing funds.  The interstate commission may not incur obligations of any kind prior to securing the funds adequate to meet the same. The interstate commission may not pledge the credit of any of the member states, except by and with the authority of the member states.   [PL 2011, c. 217, §1 (NEW).] 5.  Interstate commission to keep accurate accounts.  The interstate commission shall keep accurate accounts of all receipts and disbursements subject to the audit and accounting procedures established under its bylaws. All receipts and disbursements of funds handled by the interstate commission must be audited annually by a certified or licensed public accountant, and the report of the audit must be included in and become part of the annual report of the interstate commission.   [PL 2011, c. 217, §1 (NEW).] SECTION HISTORY PL 2011, c. 217, §1 (NEW).